The FDA approved BioFire FilmArray COVD-19 test, as well as Mesa Biotech’s Accula. Both can bring a COVID-19 diagnosis to the point of care where testing is most needed. BioFire’s Film Array has thousands of placements. Accula is a hand-held test.
We projected in Kalorama’s mPOC market study that molecular point of care ( mPOC ) would lead the fight in meeting the demand for COVID-19 testing with accurate and fast results. Lab staff is at a premium, hospitals are taxed, and testing needs to happen where it can be useful to isolate patients. We suggested that […]
A rapid scale-up of diagnostic testing for the novel coronavirus was the focus of a declaration of emergency by President Donald Trump in a March 13 press conference. The plan calls for sharply boosting the production of coronavirus test kits while also making tests available at a network of drive-through sites. In an address at the […]
Molecular point-of-care diagnostic solutions offer improvements in the sensitivity and specificity of existing near-patient and rapid tests while expanding the diagnostic capabilities at points of care, such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world, and are used to assess conditions or admit patients. The concept […]
Kalorama has released its 12th Edition of The Worldwide Market for In Vitro Diagnostic Tests. It is a complete market study of the 69+ billion-dollar industry. Among the report’s findings are the following: Some Improvement in European IVD Markets: Kalorama found reversed austerity, LDT spending, and test innovation increased Europe market size, somewhat. As Europe is an important market, this boosted the IVD market as a whole. New […]
ARLINGTON, VA., The world market for diagnostics is estimated at $69.2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85.2 billion by 2024. This is according to an upcoming report by market researcher Kalorama Information, part of Science and Medicine Group. This estimate includes all laboratory and […]
Kalorama Information attended the American Association of Clinical Chemistry in Anaheim this year. We analyzed products and trends, interviewed vendors and experts, and gathered information for our 12 Edition Worldwide Market for In Vitro Diagnostics Tests report, due out this month. Time is of the essence, it is said, and that was the case […]
We have just published our latest report, The World Market for Biomarkers. Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, […]
We recently published a customer experience survey. This blog highlights discusses the report and highlights the major findings of the report, including important recommendations for the clinical diagnostics industry. For specific vendor performance and user ratings, a purchase of the report is suggested. Clinical laboratory customers have become increasingly sophisticated and typically have multiple suppliers […]
By Emily Hayes, LabPulse.com editor in chief FROM Kalorama’s partner publication Lab Pulse.com Testing for the tau protein in blood could help predict the outlook for the rare and deadly Creutzfeldt-Jakob disease (CJD), a discovery that also has implications for research in Alzheimer’s disease and other neurodegenerative disorders, researchers reported in JAMA Neurology on May 6. Tau is […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
